We are live on ! Find out more
FBRX icon

Forte Biosciences
FBRX

34 hedge funds and large institutions have $15.5M invested in Forte Biosciences in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,500% more call options, than puts

Call options by funds: $26K | Put options by funds: $1K

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

40% more capital invested

Capital invested by funds: $11.1M → $15.5M (+$4.45M)

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

13% more funds holding

Funds holding: 30 → 34 (+4)

0.24% more ownership

Funds ownership: 1.84% → 2.08% (+0.24%)

Holders
34
Holders Change
+4
Holders Change %
+13.33%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
5
Closed
1
Calls
$26K
Puts
$1K
Net Calls
+$25K
Net Calls Change
-$84K

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$71.7K
2
TSS
Two Sigma Securities
New York
+$8.62K
3
Citadel Advisors
Citadel Advisors
Florida
+$4.82K
4
Renaissance Technologies
Renaissance Technologies
New York
+$1.62K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.45K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$7.26K
2
Jane Street
Jane Street
New York
-$7.13K
3
UBS Group
UBS Group
Switzerland
-$1.3K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$1.23K
5
Bank of America
Bank of America
North Carolina
-$349
Name Holding Trade Value Shares
Change 		Change in
Stake
TCM
1
Tybourne Capital Management
Hong Kong
$2.98M – – –
PA
2
Perceptive Advisors
New York
$2.68M – – –
BI
3
BVF Inc
California
$2.45M – – –
CCC
4
Cable Car Capital
California
$1.67M +$1.14M +81,279 New
FAM
5
Fred Alger Management
New York
$1.51M – – –
FCM
6
Farallon Capital Management
California
$1.49M – – –
BCM
7
BML Capital Management
Indiana
$1.45M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$547K +$224 +16 +0.1%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$277K +$71.7K +5,129 +62%
BlackRock
10
BlackRock
New York
$150K +$84 +6 +0.1%
Renaissance Technologies
11
Renaissance Technologies
New York
$107K +$1.62K +116 +2%
State Street
12
State Street
Massachusetts
$34.2K – – –
Two Sigma Investments
13
Two Sigma Investments
New York
$33.7K -$224 -16 -1%
Northern Trust
14
Northern Trust
Illinois
$22.1K – – –
Two Sigma Advisers
15
Two Sigma Advisers
New York
$20.4K -$1.23K -88 -8%
Goldman Sachs
16
Goldman Sachs
New York
$17K -$7.26K -520 -39%
Group One Trading
17
Group One Trading
Illinois
$13K – – –
TSS
18
Two Sigma Securities
New York
$12.7K +$8.62K +617 New
AWM
19
Aries Wealth Management
Maine
$10.7K – – –
HSBC Holdings
20
HSBC Holdings
United Kingdom
$8.7K – – –
Citadel Advisors
21
Citadel Advisors
Florida
$7.08K +$4.82K +345 New
TRCT
22
Tower Research Capital (TRC)
New York
$4.75K +$1.45K +104 +82%
CG
23
Cutler Group
California
$3K – – –
LA
24
LM Advisors
California
$2.08K +$1.41K +101 New
Morgan Stanley
25
Morgan Stanley
New York
$1.63K +$559 +40 +100%
1
2

FBRX Hedge Fund Activity: Q4 2023 in Review

34 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q4 2023, worth a combined $15.5M — up 40% from $11.1M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new FBRX positions and 1 closed out — a net gain of 4 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $71.7K. The largest seller was Goldman Sachs, cutting an estimated $7.26K.

  • 34 institutional investors held Forte Biosciences (FBRX) as of Q4 2023, up from 30 in Q3 2023.
  • Funds reported $15.5M of Forte Biosciences stock for Q4 2023, up 40% quarter-over-quarter.
  • 5 funds opened new Forte Biosciences positions in Q4 2023 and 1 closed out, a net change of +4 holders.
  • The largest Forte Biosciences buyer in Q4 2023 was Geode Capital Management, an estimated $71.7K added.
  • The largest Forte Biosciences seller in Q4 2023 was Goldman Sachs, an estimated $7.26K sold.

Based on aggregated 13F filings for Q4 2023.